CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia

Immunotherapy with CD123-specific T-cell engager proteins or with T cells expressing CD123-specific chimeric antigen receptors is actively being pursued for acute myeloid leukemia. T cells secreting bispecific engager molecules (ENG-T cells) may present a promising alternative to these approaches. T...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Ther
Autors principals: Bonifant, Challice L, Szoor, Arpad, Torres, David, Joseph, Nicholos, Velasquez, Mireya Paulina, Iwahori, Kota, Gaikwad, Amos, Nguyen, Phuong, Arber, Caroline, Song, Xiao-Tong, Redell, Michele, Gottschalk, Stephen
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5113097/
https://ncbi.nlm.nih.gov/pubmed/27401038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2016.116
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars